| Literature DB >> 12601482 |
I G H Schmidt-Wolf1, J K Rockstroh2, H Schüller3, A Hirner4, C Grohe5, H K Müller-Hermelink6, D Huhn7.
Abstract
Classification, understanding of the pathophysiology, and treatment options of thymoma have changed during recent years. It is hoped that novel strategies will lead to a survival benefit in these patients. It has become clear that patients with thymoma are best treated with multimodality therapy. In this review, a pathologist, an immunologist, a surgeon, a radiotherapist, a pneumologist, and oncologists discuss the current status of classification and strategies for the treatment of patients with thymoma.Entities:
Mesh：
Year: 2003 PMID： 12601482 DOI： 10.1007/s00277-002-0597-6
Source DB: PubMed Journal: Ann Hematol ISSN： 0939-5555 Impact factor: 3.673